Common use of Timeline Extension or Deferral of Disclosures Clause in Contracts

Timeline Extension or Deferral of Disclosures. 9.4.1 Each Party agrees that it will not unreasonably withhold, condition or delay its consent to requests for extensions of the above timelines in this ARTICLE 9 in the event that material late breaking Data becomes available. 9.4.2 If either Party believes that any proposed press release or other public statement, or any publication, presentation, or other disclosure would be prejudicial to its opportunity to obtain any Patent, then the affected Party shall notify the publishing Party within the timeframe provided for in this ARTICLE 9 as applicable, or if not applicable, as soon as practicable after receipt of the proposed press release or other public statement, publication, presentation, or other disclosure, and the publishing Party shall refrain from making such press release, other public statement, publication, presentation or other disclosure for an additional [***] Business Days from the last day of the period otherwise provided for herein to enable the preparation and filing of any necessary patent applications.

Appears in 2 contracts

Samples: License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.), License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Timeline Extension or Deferral of Disclosures. 9.4.1 Each Party agrees that it will not unreasonably withhold, condition or delay its consent to requests for extensions of the above timelines in this ARTICLE 9 13 in the event that material late breaking Data becomes available. 9.4.2 . If either Party believes that any proposed press release or other public statement, or any publication, presentation, or other disclosure would be prejudicial to its opportunity to obtain any PatentPatent Right, then the affected Party shall notify the publishing Party within the timeframe provided for in this ARTICLE 9 13 as applicable, or if not applicable, as soon as practicable after receipt of the proposed press release or other public statement, publication, presentation, or other disclosure, and the publishing Party shall refrain from making such press release, other public statement, publication, presentation or other disclosure for an additional [***] Business Days days from the last day of the period otherwise provided for herein to enable the preparation and filing of any necessary patent applications.

Appears in 1 contract

Samples: Exclusive License and Collaboration Agreement (Allogene Therapeutics, Inc.)

Timeline Extension or Deferral of Disclosures. 9.4.1 12.6.1 Each Party agrees that it will not unreasonably withhold, condition or delay its consent to requests for extensions of the above timelines in this ARTICLE 9 Article 12 in the event that material late late-breaking Data becomes available. 9.4.2 12.6.2 If either Party believes that any proposed press release or other public statement, or any publication, presentation, presentation or other disclosure would be prejudicial to its opportunity to obtain any Patent, then the affected Party shall notify the publishing Party within the timeframe provided for in this ARTICLE 9 Article 12 as applicable, or if not applicable, as soon as practicable after receipt of the proposed press release or other public statement, publication, presentation, presentation or other disclosure, and the publishing Party shall refrain from making such press release, other public statement, publication, presentation or other disclosure for an additional [***] Business Days * from the last day of the period otherwise provided for herein to enable the preparation and filing of any necessary patent applications.

Appears in 1 contract

Samples: Exclusive License and Collaboration Agreement (Cti Biopharma Corp)

Timeline Extension or Deferral of Disclosures. 9.4.1 4.6.1. Each Party agrees that it will not unreasonably withhold, condition or delay its consent to requests for extensions of the above timelines in this ARTICLE 9 Article 4 in the event that material late late-breaking Data becomes available. 9.4.2 4.6.2. If either Party believes that any proposed press release or other public statement, or any publication, presentation, presentation or other disclosure would be prejudicial to its opportunity to obtain any Patent, then the affected Party shall notify the publishing Party within the timeframe provided for in this ARTICLE 9 Article 4 as applicable, or if not applicable, as soon as practicable after receipt of the proposed press release or other public statement, publication, presentation, presentation or other disclosure, and the publishing Party shall refrain from making such press release, other public statement, publication, presentation or other disclosure for an additional [***] forty-five (45) Business Days from the last day of the period otherwise provided for herein to enable the preparation and filing of any necessary patent applications.

Appears in 1 contract

Samples: Termination and Transfer Agreement (Cti Biopharma Corp)

AutoNDA by SimpleDocs

Timeline Extension or Deferral of Disclosures. 9.4.1 12.6.1 Each Party agrees that it will not unreasonably withhold, condition or delay its consent to requests for extensions of the above timelines in this ARTICLE 9 Article 12 in the event that material late breaking Data becomes available. 9.4.2 12.6.2 If either Party believes that any proposed press release or other public statement, or any publication, presentation, or other disclosure would be prejudicial to its opportunity to obtain any Patent, then the affected Party shall notify the publishing Party within the timeframe provided for in this ARTICLE 9 Article 12 as applicable, or if not applicable, as soon as practicable after receipt of the proposed press release or other public statement, publication, presentation, or other disclosure, and the publishing Party shall refrain from making such press release, other public statement, publication, presentation or other disclosure for an additional [***] Business Days * from the last day of the period otherwise provided for herein to enable the preparation and filing of any necessary patent applications.

Appears in 1 contract

Samples: Exclusive License and Collaboration Agreement (Cti Biopharma Corp)

Timeline Extension or Deferral of Disclosures. 9.4.1 13.5.1 Each Party agrees that it will not unreasonably withhold, condition condition, or delay its consent to requests for extensions of the above timelines in this ARTICLE 9 Section 13 in the event that material late breaking Data becomes available. 9.4.2 13.5.2 If either Party believes that any proposed press release or other public statement, or any publication, presentation, or other disclosure would be prejudicial to its opportunity to obtain any Patent, then the affected Party shall notify the publishing Party within the timeframe provided for in this ARTICLE 9 Section 13 as applicable, or if not applicable, as soon as practicable after receipt of the proposed press release or other public statement, publication, presentation, or other disclosure, and in which case the publishing Party shall refrain from making such press release, other public statement, publication, presentation or other disclosure for an additional [***] Business Days from the last day of the period otherwise provided for herein to the extent necessary to enable the preparation and filing of any necessary patent applications.

Appears in 1 contract

Samples: License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!